Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bonardi

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Bioorganic Chemistry|June 29, 2026
Rational design and synthesis of pyrazole-based sulfonamides as dual carbonic anhydrase and PRAK-targeting anticancer agentsMariam M Fakhry, Mohamed A Said, Noha Zeidan, et al.
European Journal of Medicinal Chemistry|October 20, 2019
3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insightsMahmoud F Abo-Ashour, Wagdy M Eldehna, Alessio Nocentini, et al.
Cells|October 23, 2021
Carbonic Anhydrase IV Selective Inhibitors Counteract the Development of Colitis-Associated Visceral Pain in RatsElena Lucarini, Alessio Nocentini, Alessandro Bonardi, et al.
Bioorganic Chemistry|July 13, 2019
Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activityWagdy M Eldehna, Mohamed A Abdelrahman, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry|November 17, 2018
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agentsWagdy M Eldehna, Mahmoud F Abo-Ashour, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry|February 16, 2023
4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessmentsMahmoud A Ragab, Wagdy M Eldehna, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic AnhydrasesAlessio Nocentini, Simone Giovannuzzi, Vincenzo Alterio, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluationMohamed A Said, Wagdy M Eldehna, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|November 17, 2024
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer CellsWagdy M Eldehna, Mohamed Fares, Alessandro Bonardi, et al.
European Journal of Medicinal Chemistry|April 11, 2018
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agentsNiccolò Chiaramonte, Silvia Bua, Marta Ferraroni, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Bioorganic Chemistry|June 29, 2026
Rational design and synthesis of pyrazole-based sulfonamides as dual carbonic anhydrase and PRAK-targeting anticancer agentsMariam M Fakhry, Mohamed A Said, Noha Zeidan, et al.
European Journal of Medicinal Chemistry|October 20, 2019
3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insightsMahmoud F Abo-Ashour, Wagdy M Eldehna, Alessio Nocentini, et al.
Cells|October 23, 2021
Carbonic Anhydrase IV Selective Inhibitors Counteract the Development of Colitis-Associated Visceral Pain in RatsElena Lucarini, Alessio Nocentini, Alessandro Bonardi, et al.
Bioorganic Chemistry|July 13, 2019
Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activityWagdy M Eldehna, Mohamed A Abdelrahman, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry|November 17, 2018
Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agentsWagdy M Eldehna, Mahmoud F Abo-Ashour, Alessio Nocentini, et al.
European Journal of Medicinal Chemistry|February 16, 2023
4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessmentsMahmoud A Ragab, Wagdy M Eldehna, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic AnhydrasesAlessio Nocentini, Simone Giovannuzzi, Vincenzo Alterio, et al.
European Journal of Medicinal Chemistry|January 24, 2020
Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluationMohamed A Said, Wagdy M Eldehna, Alessio Nocentini, et al.
Journal of Medicinal Chemistry|November 17, 2024
4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer CellsWagdy M Eldehna, Mohamed Fares, Alessandro Bonardi, et al.
European Journal of Medicinal Chemistry|April 11, 2018
2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agentsNiccolò Chiaramonte, Silvia Bua, Marta Ferraroni, et al.
Pageof 11